@FiercePharma: Ranbaxy could waive Lipitor rights, let a rival generic to market...for a fee. If it can't get straight with FDA first. Article | Follow @FiercePharma
> Sandoz has asked a U.S. court to rule that its knock-off version of Novo Nordisk's diabetes drug Prandin will not infringe on the Danish company's patent. News
> Celgene's ($CELG) board authorized another $2 billion in stock buy-backs, adding to the $2.25 billion left from a previous program. Item
> Apricus Biosciences ($APRI) got the FDA nod for its Tolnaftate-D antifungal cream, its first product to be sold in the U.S. Story
> Swiss drugmaker Basilea Pharmaceutica posted a narrower net loss as a loss of contract revenue was partly offset by growing product sales. Article
> Merck's ($MRK) consumer products group is hunting for a global agency to handle its over-the-counter drug brands. Report
> Sagent Pharmaceuticals ($SGNT) launched its version of Norcuron, an injectable treatment for myasthenia gravis. News
> Valeant Pharmaceuticals ($VRX) said board member Michael Van Every has resigned for health reasons. Item
Biotech News
@FierceBiotech: Stanford investigators use "online dating" to match old drugs with new medical uses. Story | Follow @FierceBiotech
@JohnCFierce: Funny Icahn threat in conceding Forest bod vote. Imclone, Biogen, Genzyme all took time. (I'll be baa-a-a-ack.) More | Follow @JohnCFierce
@RyanMFierce: Hmm. Ireland-based academic says that private biotech spinoffs do better than those from universities Piece | Follow @RyanMFierce
@MaureenFierce: The other dark side of Merck's 13,000 layoffs: pharma's moving to greener pastures. Story | Follow @MaureenFierce
> GSK-owned Sirtris drug extends lives of obese mice. Story
> Dendreon's fall trips up fellow biotechs on Wall Street. News
> Roche targets 'good cholesterol' drug win where rivals failed. Story
> Biotech venture to create 150 jobs in Florida. Article
> Amgen drug shows it can 'improve heart function' in Ph2. News
> China draws expats from U.S. to launch biotechs. Item
And Finally... One in 5 people seeking bankruptcy protection blames medical bills. Report